AssetMark Inc
IRON icon

AssetMark Inc’s Disc Medicine IRON Stock Holding History

AssetMark Inc’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$878 Hold
12
– – ﹤0.01% 3174
2026
Q1 		$767 Hold
12
– – ﹤0.01% 3092
2025
Q4 		$953 Hold
12
– – ﹤0.01% 2950
2025
Q3 		$793 Hold
12
– – ﹤0.01% 2836
2025
Q2 		$636 Hold
12
– – ﹤0.01% 2698
2025
Q1 		$596 Buy
+12
New +$667 ﹤0.01% 2385

Other funds holding IRON

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

AssetMark Inc's IRON Position: Q2 2026 in Review

AssetMark Inc held its Disc Medicine (IRON) position steady in Q2 2026 at 12 shares worth $878. The position accounts for ﹤0.01% of the portfolio, ranked #3174.

AssetMark Inc first reported a position in IRON in Q1 2025 and has held it in 6 quarters since. The position peaked at $953 in Q4 2025. 49 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • AssetMark Inc held 12 shares of Disc Medicine worth $878 as of Q2 2026.
  • AssetMark Inc left its Disc Medicine share count unchanged in Q2 2026.
  • Disc Medicine made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #3174 holding.
  • AssetMark Inc first reported a position in Disc Medicine in Q1 2025 and has held it in 6 quarters since.
  • AssetMark Inc's Disc Medicine position peaked at $953 in Q4 2025.
  • 49 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.